Federated Hermes’s SOPHiA GENETICS SOPH Stock Holding History

Federated Hermes’s Portfolio SOPH Stock Details SOPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$819K	Sell	141,992 -48,018	-25%	-$244K	﹤0.01%	1201
2026 Q1	$941K	Buy	190,010 +2,333	+1%	+$11.3K	﹤0.01%	1132
2025 Q4	$876K	Sell	187,677 -22,323	-11%	-$101K	﹤0.01%	1159
2025 Q3	$1,000K	Sell	210,000 -10,000	-5%	-$34.4K	﹤0.01%	1148
2025 Q2	$682K	Buy	220,000 +31,000	+16%	+$92.4K	﹤0.01%	1248
2025 Q1	$627K	Buy	189,000 +89,000	+89%	+$313K	﹤0.01%	1242
2024 Q4	$312K	Buy	100,000 +28,819	+40%	+$98.1K	﹤0.01%	1418
2024 Q3	$259K	Buy	71,181 +8,181	+13%	+$33.2K	﹤0.01%	1444
2024 Q2	$289K	Buy	63,000 +23,000	+58%	+$112K	﹤0.01%	1419
2024 Q1	$197K	Sell	40,000 -80,000	-67%	-$386K	﹤0.01%	1494
2023 Q4	$565K	Sell	120,000 -40,000	-25%	-$150K	﹤0.01%	1312
2023 Q3	$408K	Buy	160,000 +80,000	+100%	+$254K	﹤0.01%	1398
2023 Q2	$358K	Buy	80,000 +15,487	+24%	+$70K	﹤0.01%	1463
2023 Q1	$321K	Sell	64,513 -35,487	-35%	-$115K	﹤0.01%	1511
2022 Q4	$206K	Buy	+100,000	New	+$225K	﹤0.01%	1552

Other funds holding SOPH

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

ACM

AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Federated Hermes's SOPH Position: Q2 2026 in Review

Federated Hermes reduced its SOPHiA GENETICS (SOPH) stake by 25% in Q2 2026, selling an estimated $244K and leaving 141,992 shares worth $819K. The position accounts for ﹤0.01% of the portfolio, ranked #1201.

Federated Hermes first reported a position in SOPH in Q4 2022 and has held it in 15 quarters since. The position peaked at $1,000K in Q3 2025. 71 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

Federated Hermes held 141,992 shares of SOPHiA GENETICS worth $819K as of Q2 2026.
Federated Hermes sold 48,018 SOPHiA GENETICS shares in Q2 2026, an estimated $244K.
SOPHiA GENETICS made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1201 holding.
Federated Hermes first reported a position in SOPHiA GENETICS in Q4 2022 and has held it in 15 quarters since.
Federated Hermes's SOPHiA GENETICS position peaked at $1,000K in Q3 2025.
71 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.